Skip to main content
Dyadic International, Inc. (DYAI)
NASDAQ: DYAI · Real-Time Price · USD
0.810
-0.010 (-1.21%)
At close: Apr 28, 2026, 4:00 PM EDT
0.800
-0.010 (-1.25%)
Pre-market: Apr 29, 2026, 8:12 AM EDT

Dyadic International Revenue

In the year 2025, Dyadic International had annual revenue of $3.09M, down -11.59%. Dyadic International had revenue of $565.53K in the quarter ending December 31, 2025, a decrease of -30.81%.

Revenue (ttm)
$3.09M
Revenue Growth
-11.59%
P/S Ratio
9.55
Revenue / Employee
$515,058
Employees
6
Market Cap
29.52M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20253.09M-405.04K-11.59%
Dec 31, 20243.50M596.58K20.58%
Dec 31, 20232.90M-31.50K-1.07%
Dec 31, 20222.93M526.47K21.90%
Dec 31, 20212.40M801.91K50.06%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Celularity 40.58M
Evaxion 7.53M
Pluri 1.34M
IGC Pharma 1.11M
Daré Bioscience 1.03M
Outlook Therapeutics 205.70K
Lisata Therapeutics 170.00K
Senti Biosciences 22.00K
Revenue Rankings

DYAI News

More News